Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Related TRIB
Worst Performing Industries For November 3, 2014
Trinity Biotech Announces Quarter 3 Financial Results And Temporary Suspension Of Meritas Troponin Trials
Related VIVO
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.11%. TRIB's revenue for the same period is $79.32 million.

The trailing-twelve-month profit margin at Meridian Bioscience Inc (NASDAQ: VIVO) is 17.59%. VIVO's PEG ratio is 1.27.

The trailing-twelve-month profit margin at Neogen Corp (NASDAQ: NEOG) is 12.53%. NEOG's operating margin for the same period is 18.75%.

The trailing-twelve-month profit margin at Abaxis Inc (NASDAQ: ABAX) is 8.36%. ABAX's ROE for the same period is 7.97%.

Posted-In: Diagnostic Substances Industry Highest Profit Margin small-capTrading Ideas

 

Related Articles (ABAX + NEOG)

Around the Web, We're Loving...

Get Benzinga's Newsletters